rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2002-6-7
|
pubmed:abstractText |
The purpose of this study was to determine the efficacy, tolerability, and pharmacokinetics of intraperitoneal (ip) paclitaxel combined with intravenous (iv) carboplatin and cyclophosphamide.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0090-8258
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
517-23
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:12051884-Adult,
pubmed-meshheading:12051884-Aged,
pubmed-meshheading:12051884-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12051884-Carboplatin,
pubmed-meshheading:12051884-Combined Modality Therapy,
pubmed-meshheading:12051884-Cyclophosphamide,
pubmed-meshheading:12051884-Female,
pubmed-meshheading:12051884-Humans,
pubmed-meshheading:12051884-Infusions, Parenteral,
pubmed-meshheading:12051884-Middle Aged,
pubmed-meshheading:12051884-Ovarian Neoplasms,
pubmed-meshheading:12051884-Paclitaxel
|
pubmed:year |
2002
|
pubmed:articleTitle |
Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer.
|
pubmed:affiliation |
Department of Medical Oncology, University Hospital Groningen, Groningen, The Netherlands.
|
pubmed:publicationType |
Journal Article
|